<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2008</study_start_year><condition>Neoplasm Metastasis</condition><condition>Colorectal Cancer</condition><condition>Liver Metastasis</condition><condition>Colorectal Neoplasms</condition><condition>colorectal cancers</condition><disease>Neoplasm Metastasis</disease><disease>Colorectal Cancers</disease><disease>Colorectal Cancer</disease><disease>Liver Metastasis</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2049091</full_dataset_link><location>Japan</location><study_start_month>1</study_start_month><keyword>Neoadjuvant chemotherapy</keyword><keyword>Metastatic liver lesions from colorectal cancers</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers</name><description>The purpose of this study is to evaluate the safety of liver resection for metastatic, resectable lesions from colorectal cancers after systemic chemotherapy.</description><dates><creation>2008-01-15</creation></dates><accession>2049091</accession><cross_references><University Hospital Medical Information Network CTR>UMIN000000961</University Hospital Medical Information Network CTR><ClinicalTrials___gov>NCT00594529</ClinicalTrials___gov><Japan Primary Registries Network>JPRN-UMIN000000961</Japan Primary Registries Network></cross_references></HashMap>